For the Inventor, By the Inventor

Enter assignee name

Patterson, NY, United States of America

Edward Mendell Co., Inc.

Calculating rank

USPTO Granted Patents = 47

% Expired Patents = 4.3

Trademarks = 6

Forward Citations = 2,000

Loading Chart...

Loading Chart...

11 inventors (with patents filed for the assignee):

Anand R Baichwal (28 out of 50 patents)

John Nicholas Staniforth (18 out of 83 patents)

Bob E Sherwood (18 out of 25 patents)

4. Edward A Hunter (17 out of 30 patents)

5. John H Staniforth (5 out of 7 patents)

6. Joseph A Zeleznik (4 out of 6 patents)

7. Troy W McCall (3 out of 3 patents)

8. Dileep Bhagwat (1 out of 16 patents)

9. Donald Diehl, Ii (1 out of 3 patents)

10. Clifford M Davidson (1 out of 2 patents)

11. Jouko Johannes Virtanen (1 out of 1 patent)

Core Competencies:

Pharmaceutical Excipient

Sustained Release

Controlled Release

Microcrystalline Cellulose

Hydrogel Systems

Acetaminophen Formulations

Bioadhesive Tablet

Metoprolol

Oxybutynin

Verapamil Tablets

Solid Dosage Forms

Agglomerated Complexes

47 patents: Sort by Forward Citations

1. 6660303 - Pharmaceutical superdisintegrant (2003-12-09),

2. 6521261 - Pharmaceutical excipient having improved compressibility (2003-02-18),

3. 6471994 - Pharmaceutical excipient having improved compressibility (2002-10-29),

4. 6395303 - Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose (2002-05-28),

5. 6391337 - Directly compressible high load acetaminophen formulations (2002-05-21),

6. 6358533 - Pharmaceutical excipient having improved compressibility (2002-03-19),

7. 6245356 - Sustained release heterodisperse hydrogel systems-amorphous drugs (2001-06-12),

8. 6245355 - Sustained release matrix for high-dose insoluble drugs (2001-06-12),

9. 6217909 - Pharmaceutical excipient having improved compressibility (2001-04-17),

10. 6217907 - Directly compressible high load acetaminophen formulations (2001-04-17),

11. 6136343 - Sustained release heterodisperse hydrogel systems for insoluble drugs (2000-10-24),

12. 6106865 - Pharmaceutical excipient having improved compressibility (2000-08-22),

13. 6103219 - Pharmaceutical excipient having improved compressibility (2000-08-15),

14. 6093420 - Sustained release matrix for high-dose insoluble drugs (2000-07-25),

15. 6056977 - Once-a-day controlled release sulfonylurea formulation (2000-05-02),

Company Overview

Edward Mendell Co., Inc., based in Patterson, NY, specializes in the development and manufacturing of pharmaceutical excipients and advanced formulation technologies. The company focuses on creating sustained release matrices and controlled release formulations, catering to the needs of the pharmaceutical industry. Their expertise extends to directly compressible formulations, hydrophilic complexes, and microcrystalline cellulose, enabling the effective delivery of bioadhesive tablets and the management of insoluble drugs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

47 Patents

#1 in Patterson, NY

#465 in New York

#7,448 in US

#14,840 in the World

Patterson, NY, United States of America

Edward Mendell Co., Inc.

Forward Citations = 2,000

11 inventors:

Anand R Baichwal (28 out of 50 patents)

John Nicholas Staniforth (18 out of 83 patents)

Bob E Sherwood (18 out of 25 patents)

4. Edward A Hunter (17 out of 30 patents)

5. John H Staniforth (5 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Edward Mendell Co., Inc.. Retrieved from https://idiyas.com/company/edward-mendell-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…